HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ADAMTS13, FVIII, von Willebrand factor, ABO blood group assessment in preeclampsia.

AbstractINTRODUCTION:
Preeclampsia (PE) is a multifactorial disease characterized by high blood pressure and proteinuria after the 20th week of pregnancy. PE is associated with fibrin deposition in placental microcirculation and intrauterine fetal growth retardation. We evaluated FVIII activity, VWF and ADAMTS13 plasma levels, according to O and "non O" blood groups, in women with severe PE (sPE).
METHODS:
This case-control study included 140 women; 55 pregnant with sPE, 35 normotensive pregnant and 50 non-pregnant women. VWF and ADAMTS13 antigen levels were assessed by ELISA (American Diagnostica). FVIII activity was measured by automated coagulometric method (Dade Behring) and ABO blood groups phenotyping was performed by indirect technique.
RESULTS:
FVIII activity and VWF levels were significantly higher comparing either sPE to normotensive pregnant (P=0.01; P=0.05) and to non-pregnant women (P=0.00 in both cases) or normotensive pregnant and non-pregnant women (P=0.00 in both cases). A significant decrease in ADAMTS13 levels was observed comparing either sPE to normotensive pregnant (P=0.02) and non-pregnant women (P=0.00) or normotensive pregnant and non-pregnant women (P=0.00). FVIII activity and VWF levels were associated to O and "non O" blood groups only in non-pregnant women.
CONCLUSIONS:
The increase of FVIII activity and VWF levels and the decrease of ADAMTS13 in sPE are not associated to O and "non O" blood groups. These alterations in hemostatic markers in sPE largely surpass those physiologically determined by ABO blood groups influence and may have masked the effect of O and "non O" groups in this disease. A concomitant analysis of VWF levels and ADAMTS13 activity and antigenic levels will be important to clarify the imbalance between these parameters found in sPE in the present study.
AuthorsPatrícia N Alpoim, Karina B Gomes, Lara C Godoi, Danyelle R Rios, Maria G Carvalho, Ana P Fernandes, Luci M Dusse
JournalClinica chimica acta; international journal of clinical chemistry (Clin Chim Acta) Vol. 412 Issue 23-24 Pg. 2162-6 (Nov 20 2011) ISSN: 1873-3492 [Electronic] Netherlands
PMID21840304 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2011 Elsevier B.V. All rights reserved.
Chemical References
  • ABO Blood-Group System
  • von Willebrand Factor
  • ADAM Proteins
  • ADAMTS13 Protein
  • ADAMTS13 protein, human
Topics
  • ABO Blood-Group System
  • ADAM Proteins (metabolism)
  • ADAMTS13 Protein
  • Female
  • Humans
  • Pre-Eclampsia (blood)
  • Pregnancy
  • von Willebrand Factor (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: